Literature DB >> 20457203

Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure.

Aysegul Cort1, Nihal Ozturk, Deniz Akpinar, Mustafa Unal, Gultekin Yucel, Akif Ciftcioglu, Piraye Yargicoglu, Mutay Aslan.   

Abstract

The aim of this study was to clarify the possible protective effect of astaxanthin (ASX) on the retina in rats with elevated intraocular pressure (EIOP). Rats were randomly divided into two groups which received olive oil or 5mg/kg/day ASX for a period of 8 weeks. Elevated intraocular pressure was induced by unilaterally cauterizing three episcleral vessels and the unoperated eye served as control. At the end of the experimental period, neuroprotective effect of ASX was determined via electrophysiological measurements of visual evoked potentials (VEP) and rats were subsequently sacrificed to obtain enucleated globes which were divided into four groups including control, ASX treated, EIOP, EIOP+ASX treated. Retinoprotective properties of ASX were determined by evaluating retinal apoptosis, protein carbonyl levels and nitric oxide synthase-2 (NOS-2) expression. Latencies of all VEP components were significantly prolonged in EIOP and returned to control levels following ASX administration. When compared to controls, EIOP significantly increased retinal protein oxidation which returned to baseline levels in ASX treated EIOP group. NOS-2 expression determined by Western blot analysis and immunohistochemical staining was significantly greater in rats with EIOP compared to ASX and control groups. Retinal TUNEL staining showed apoptosis in all EIOP groups; however ASX treatment significantly decreased the percent of apoptotic cells when compared to non treated ocular hypertensive controls. The presented data confirm the role of oxidative injury in EIOP and highlight the protective effect of ASX in ocular hypertension. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457203     DOI: 10.1016/j.yrtph.2010.05.001

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  8 in total

1.  Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats.

Authors:  Serdar Dogan; Mustafa Unal; Nihal Ozturk; Piraye Yargicoglu; Aysegul Cort; Ivan Spasojevic; Ines Batinic-Haberle; Mutay Aslan
Journal:  Exp Eye Res       Date:  2011-06-12       Impact factor: 3.467

Review 2.  Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases.

Authors:  Ming Yang; Yanling Wang
Journal:  J Ophthalmol       Date:  2022-05-20       Impact factor: 1.974

Review 3.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

4.  Astaxanthin increases progesterone production in cultured bovine luteal cells.

Authors:  Hachiro Kamada; Satoshi Akagi; Shinya Watanabe
Journal:  J Vet Med Sci       Date:  2017-04-23       Impact factor: 1.267

Review 5.  Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications.

Authors:  Zohreh Jafari; Ashkan Bigham; Sahar Sadeghi; Sayed Mehdi Dehdashti; Navid Rabiee; Alireza Abedivash; Mojtaba Bagherzadeh; Behzad Nasseri; Hassan Karimi-Maleh; Esmaeel Sharifi; Rajender S Varma; Pooyan Makvandi
Journal:  J Med Chem       Date:  2021-12-17       Impact factor: 7.446

Review 6.  Pharmaceutical and nutraceutical potential of natural bioactive pigment: astaxanthin.

Authors:  Apurva D Patil; Pramod J Kasabe; Padma B Dandge
Journal:  Nat Prod Bioprospect       Date:  2022-07-07

Review 7.  Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights.

Authors:  Giuseppe Giannaccare; Marco Pellegrini; Carlotta Senni; Federico Bernabei; Vincenzo Scorcia; Arrigo Francesco Giuseppe Cicero
Journal:  Mar Drugs       Date:  2020-05-01       Impact factor: 5.118

8.  Preparation and Characterization of Microemulsions Based on Antarctic Krill Oil.

Authors:  Jiawen Zhao; Kening Jiang; Yixuan Chen; Juan Chen; Yangfan Zheng; Huilin Yu; Jiajin Zhu
Journal:  Mar Drugs       Date:  2020-09-25       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.